Inflammation
Severe inflammation ➤ cancer 
DNA damage

Mutations Mutations
Mcc deletion suppresses the repair of inflammationinduced DNA damage and promotes cancer in the mouse colon.
SUMMARY
A new Mcc-knockout mouse model shows impairment of DNA repair pathways in drug-induced inflammatory lesions leading to cancer development. The lesions show a strong interferon-g response regardless of Mcc expression, including novel Irg genes not previously described in the mouse colon.
BACKGROUND & AIMS:
The early events by which inflammation promotes cancer are still not fully defined. The MCC gene is silenced by promoter methylation in colitis-associated and sporadic colon tumors, but its functional significance in precancerous lesions or polyps is not known. Here, we aimed to determine the impact of Mcc deletion on the cellular pathways and carcinogenesis associated with inflammation in the mouse proximal colon.
METHODS:
We generated knockout mice with deletion of Mcc in the colonic/intestinal epithelial cells (Mcc DIEC ) or in the whole body (Mcc D/D ). Drug-induced lesions were analyzed by transcriptome profiling (at 10 weeks) and histopathology (at 20 weeks). Cell-cycle phases and DNA damage proteins were analyzed by flow cytometry and Western blot of hydrogen peroxide-treated mouse embryo fibroblasts.
RESULTS:
Transcriptome profiling of the lesions showed a strong response to colon barrier destruction, such as upregulation of key inflammation and cancer-associated genes as well as 28 interferon g-induced guanosine triphosphatase genes, including the homologs of Crohn's disease susceptibility gene IRGM. These features were shared by both Mcc-expressing and Mcc-deficient mice and many of the altered gene expression pathways were similar to the mesenchymal colorectal cancer subtype known as consensus molecular subtype 4 (CMS4). However, Mcc deletion was required for increased carcinogenesis in the lesions, with adenocarcinoma in 59% of Mcc DIEC compared with 19% of Mcc-expressing mice (P ¼ .002). This was not accompanied by hyperactivation of b-catenin, but Mcc deletion caused down-regulation of DNA repair genes and a disruption of DNA damage signaling.
T he role of inflammation as a risk factor and promoter of colorectal cancer is under intense investigation, both in colitis-associated cancer (CAC) and in sporadic tumors. There are several mouse models that have shown valuable novel insights into the etiology of CAC, but the molecular mechanisms and early events by which inflammation promotes cancer still are poorly understood. 1 The MCC gene was discovered as a result of its proximity to APC on chromosome 5, 2 but its possible significance in carcinogenesis was overlooked until recently. [3] [4] [5] [6] [7] [8] [9] In colorectal cancers, a common alteration is promoter methylation that causes MCC silencing, 3, 4, 10 most frequently in cancers of the proximal colon (58%). 11 The MCC defect appears early in premalignant tumors or lesions and is strongly associated with sessile serrated polyps (80%-86%). 4, 12, 13 Mcc mutations were identified as drivers of colon or liver carcinogenesis in transposonbased genetic screens in mice, 14, 15 but it has not been reported whether mutated in colorectal cancer (MCC) deficiency predisposes to cancer in premalignant colon tumors or lesions.
To further determine the role of MCC in carcinogenesis in vivo, we generated new knockout mouse models for Mcc. We focused on the mouse colon and hypothesized that loss of MCC would have an impact on inflammation-associated carcinogenesis in the proximal colon. Therefore, we exploited the drug sulindac, which acts as an irritant in a short region of the mouse proximal colon. [16] [17] [18] This highly localized side effect of sulindac is independent of its chemopreventive activity in experimental models of colon cancer. 16, [19] [20] [21] Initially, exposure to sulindac causes microscopic foci of surface tissue erosion. With long-term administration of the drug (10-20 wk), the foci develop into visible ulcerated lesions with chronic inflammation that are surrounded by normal tissue. Most of these lesions are benign but can develop into adenocarcinoma in strains of knockout mice with tumor-suppressor gene defects, such as Apc, p53, Msh2, and Mlh1. 16, 19, 21, 22 Here, we show that Mcc deficiency promotes carcinogenesis in this model through failure to repair inflammation-induced DNA damage. 
Results
Generation of
. The Villin-cre transgene expresses cre constitutively in the epithelial cells of the entire crypt-villus axis along the small and large intestine, but we focused on the effect of Mcc deletion in the colon. 23 Mcc expression was reduced significantly in the mucosal layer throughout the colon in the homozygous Mcc DIEC mice ( Figure 1B ). Histopathology of major organs showed no gross abnormalities or tumors in the wholebody knockout Mcc D/D mice, and there was no reduced survival after a 12-month follow-up period. However, histopathology analysis of bromodeoxyuridine (BrdU) incorporation in vivo showed that there was a 10%-20% decrease in the proliferation rate of colon epithelial cells in Mcc D/D mice compared with their wild-type (WT) siblings ( Figure 1C ). ) were given feed containing sulindac or control feed for 20 weeks. As expected, sulindac exposure caused the development of macroscopic lesions in the mucosal folds of the proximal colon. Both Mcc-expressing and Mccdeficient mice developed these drug-induced lesions and there was no difference in the size or number of the lesions, or the area of the colon affected, indicating a similar level of macroscopic tissue damage ( Figure 1D ). The lesions were mostly found in a 1-cm region of the proximal colon that previously was designated as P2 and is located 2-3 cm from the cecum. 16 Microscopically, the lesions featured mucosal surface erosion or ulceration with mixed inflammatory cell infiltrate, resulting in mild-moderate to severe acute or chronic inflammation, similar to our previous reports on this model. 16, 18 A subset of up to 4 lesions/mouse developed mucinous or nonmucinous adenocarcinoma. The frequency of cancer was 59% (13 of 22) Figure 1E .
Mcc Deficiency Drives Inflammation-Associated Cancer
Drug-Induced Colon Lesions Show Up-Regulation of Proinflammatory Genes and Down-Regulation of b-Catenin Target Genes
To determine gene expression changes in the earlier lesions we conducted transcriptome profiling after 10 weeks of sulindac exposure. The surface mucosa was harvested from proximal (P1, P2) and distal colon and microdissected separately from the macroscopic lesions. Tables 1-3 ). There were no significant differences between the genotypes for the most up-regulated genes listed in Table 1 (>12-fold (Figure 2) .
Many of the highly up-regulated genes identified in this study have been associated previously with inflammation or carcinogenesis 24, 25 and were found in both Mcc DIEC and Mcc F/F mice. They included S100A8/A9 (calprotectin), Mmp13 and other Mmps, Tgfb, Tnfa, Cox2 (Ptgs2), the interleukin 1 family of cytokines (Ilb, Ila, Il33, Il1f9), and other inflammatory or immunosuppressive factors (Cxcl2/ Mip2, Il6, Cxcl1, Cxcl9, Cxcr2, Ido1, Pd-l1/Cd274), as well as the free radical nitric oxide-producing enzyme iNos2. Epithelial mesenchymal transition (EMT)-related factors included Tgm2, Hif1a, Plaur, Plau, Dcn, Hgf, Grem1, Vim, and Fn1. Gene set enrichment analysis (GSEA) of hallmark pathways 26 showed up-regulation of several inflammation and cancer-associated pathways ( Table 2 ) that overlap with the mesenchymal subtype of colorectal cancer known as consensus molecular subtype 4 (CMS4). 27 The shared upregulated pathways were EMT, inflammatory response, angiogenesis, complement, and transforming growth factor b signaling (Table 2) . 27 Another shared feature with CMS4 was the absence of b-catenin pathway hyperactivation in both genotypes. b-catenin target genes Lgr5 and Axin2 actually were downregulated in the lesions compared with matching normal tissue from control-fed mice (Figure 2 ), similar to our previous report in Hif1a-deficient and WT mice.
18 Lgr5 expression is a key marker of colon stem cells 28, 29 and loss of these cells was reported previously in dextran sodium sulfate (DSS)-induced colitis. 30 The cancers showed no evidence of b-catenin nuclear localization and both E-cadherin and b-catenin staining was strong in the membrane of the cancer cells in Mcc-expressing and Mcc-deficient mice ( Figure 3A-D) . Thus, cancer in this model is not driven by b-catenin hyperactivation, and down-regulation of Lgr5 expression suggests loss of colon stem cells and lack of regenerative potential in the inflammatory lesions.
Among the few highly down-regulated genes were Cyp2c67, Cyp2c68, Cyp2c40, and Cyp2c69 (5-to 12-fold) from the cytochrome P450 cluster on chromosome 19, which are orthologues of the human drug response gene CYP2C9. Expression of aryl hydrocarbon receptor (Ahr), another important drug response gene, was not altered in the lesions. However, there was an increase of cytoplasmic aryl hydrocarbon receptor (AHR) protein expression in the normal-appearing colon epithelium, which is known to absorb sulindac and its metabolites ( Figure 3E-G) . 16 Inflammation Is Associated With Suppression of DNA Repair Pathways in Mcc-Deficient Mice Although strong cancer-promoting genes and pathways were highly activated in the colonic lesions of both genotype groups (Tables 1 and 2 ), only 19% of Mcc-expressing controls developed cancer compared with 59% of Mcc-deficient mice. A significant difference between the 2 genotypes was in signatures of DNA repair, DNA replication, and cell-cycle regulation. GSEA analysis showed that the hallmark pathways G2M checkpoint, E2F targets, Myelocytomatosis oncogene cellular homolog (MYC) targets, and DNA repair were down-regulated in the lesions of Mcc-deficient mice compared with the lesions of Mcc-expressing mice ( Table 2) . This is consistent with the previously identified role of MCC in the DNA damage response. 8 Further analysis of the DNA repair pathway data identified 29 genes that were down-regulated significantly in the lesions of Mcc-deficient mice ( Figure 4A ). These included the DNA mismatch repair (MMR) genes Msh3, Msh2, Mlh1, Mlh3, and Pms2. The baseline expression levels of MMR genes were similar between different regions of the colon within each group of control-fed mice (Figure 2 ). Msh2 expression was slightly higher in the colon of control-fed Mcc DIEC mice than in Mcc-expressing mice. We analyzed the lesions and cancers for microsatellite instability (MSI) of mononucleotide repeats, a known marker of complete MMR deficiency, 31, 32 but no instability was found (data not Figure 4B ). The WT MEFS showed phosphorylation of the checkpoint kinase (CHK)1 and CHK2 after H 2 O 2 addition. This is consistent with activation of DNA damage response via the serine/threonine-protein kinases ataxia telangiectasia and Rad3-related (ATR) and ataxia telangiectasia mutated (ATM) ( Figure 4C ). Mcc D/D MEFS also showed phosphorylation of CHK2, which may indicate additional signaling through other kinases apart from ATM. 33 In contrast, the ATR-related signaling pathway, which leads to phosphorylation of CHK1 and the repair of DNA singlestrand breaks (SSBs), was markedly suppressed. MCC expression itself also was induced by H 2 O 2 exposure in WT MEFs ( Figure 4C) . Surprisingly, we identified an increase in cell-cycle Sphase in Mcc D/D cells treated with H 2 O 2 for 1-6 hours. There was also a sustained S-phase in cells allowed to recover in fresh medium after a 2-hour H 2 O 2 exposure ( Figure 4D ). This led us to ask whether the increase in S phase after the DNA damage associated with MCC loss was owing to an active or arrested S-phase. We performed Western blot for the key cell-cycle regulator retinoblastoma (RB) and phosphorylated RB as a measure for an active Sphase. The WT MEFs responded to H 2 O 2 with a loss of phosphorylation of RB within 1 hour. By contrast, Mcc D/D MEFS showed sustained, or a slight increase in, phosphorylation of phosphorylated RB after exposure to H 2 O 2 ( Figure 4C ). Consequently, it appears that there is loss of DNA damage response signaling in Mcc D/D MEFS that may be accompanied by sustained proliferation. To confirm these observations, we analyzed whether MCC loss also leads to a relative increase of S-phase in UV-treated HCT116 cells, which express endogenous MCC ( Figure 4D ). Both nontargeted (NT) and MCC-knockdown (KD) cells showed a subtle increase in S-phase 24 hours after 10 J/m 2 UV treatment. However, the MCC-KD cells showed a trend for a more persistent increase in S-phase fraction at 48 hours that continued until 72 hours after treatment.
Exposure to mutagens during an active S-phase means that there is a greater likelihood that the cells sustain DNA damage, which then may be integrated into the genome through low-fidelity repair mechanisms. To test whether MCC-knockdown cells sustain greater DNA damage in Sphase, we subsequently treated HCT116 cells with SN38, which is a metabolite of the chemotherapy drug irinotecan and causes SSBs. A comet assay showed that MCCknockdown cells have greater DNA damage compared with NT cells after treatment with SN38 ( Figure 4E ). DNA damage also was increased in H 2 O 2 -treated Mcc D/D MEFS with defective CHK1 signaling. There was a strong increase of gamma histone 2AX (gH2AX), whereas in WT MEFs the increase was minimal ( Figure 4C ). gH2AX is a marker of double-strand break damage that can develop from SSB through DNA replication when SSB repair is deficient. Thus, a lack of MCC can lead to an increase in both SSB and double-strand break damage. 
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Drug-Induced Lesions Show a Strong Interferon g-Induced Guanosine Triphosphatase Response to Colon Barrier Destruction
Because the impact of Mcc deficiency on carcinogenesis was shown only in the drug-induced lesions, we proceeded to investigate if sulindac-induced colon inflammation is similar or has some unique features compared with another model of colon inflammation. Search of the literature for a comparable gene profiling study identified a report on DSS colitis that develops in the mouse mid-distal colon. 34 The gene profiles were strikingly similar between the 2 models, although the time scale of drug exposure was different, 6 days of DSS vs 10 weeks of sulindac ( Figure 5A ). Overall, the 2 studies were correlated positively (r ¼ 0.55; P < 2e-16) and 1602 differentially expressed probe sets were highly correlated (r ¼ 0.82). This is compatible with the concept that both models involve colon barrier destruction.
The top 2 GSEA hallmark pathways 26 activated in our study were interferon g (IFNg) response and EMT (Table 2) . These indicate strong responses to colon barrier destruction and bacterial invasion of the underlying tissue layers. 25, 35 A prominent feature of the colon lesions in both genotype groups was the induction of at least 28 IFNg-induced guanosine triphosphatase (GTPase) genes, usually thought to be associated with the host response to external pathogens and not previously recognized in the mouse colon. Several clusters of these genes were identified on chromosomes 3, 5, 7, 11, and 18, which also included long noncoding RNAs (Table 3) . 36 Sixteen of the up-regulated genes represent the Irg (p47-GTPase) subfamily, of which only the IRGM and IRGC genes have been retained through evolution in human beings. IRGM is a candidate for the Crohn's disease susceptibility locus. 37 We identified only 11 IFNg-induced GTPase genes in the previous generation Affymetrix array (Santa Clara, CA) used for the DSS colitis study, but most of them also were up-regulated in that study ( Figure 5A ). Therefore, up-regulation of IFNg-induced GTPases is not unique to sulindac-induced colon inflammation.
Two of the genes Irga6 (Iigp1) and Irgb6 (Tgtp2) were selected for validation by qPCR in different parts of the colon. The level of expression was variable but was increased in the sulindac-induced lesions ( Figure 5B ). To investigate the possibility that the high expression of these genes was related to an undetected pathogen infection in the animals, we analyzed colon specimens from 3 experiments over 4 years and found that Irgb6 and Irga6 genes were consistently up-regulated in sulindac-induced lesions, similar to the chemokine Mip2 ( Figure 5C ). We then treated CT26 mouse colon cancer cells in vitro with lipopolysaccharide, a component of the bacterial membrane. This treatment also induced the expression of Irgb6, Irga6, and Mip2 ( Figure 6A ), similar to the induction of proinflammatory signaling shown previously in vitro by sulindac sulfide. 17, 18 Therefore, the strong expression of multiple IFNg-induced GTPases is a previously unrecognized feature of mouse colitis that is not necessarily related to an external pathogen infection, but can be triggered by gut bacteria invading the submucosa and causing inflammation after sulindac-induced initial injury. Proinflammatory factors also can induce the same response in vitro.
We analyzed the protein expression of 2 of the highly up-regulated genes Irga6 and Irgm3. There was no expression of Immunity-related GTPase A6 (IRGA6) in the normal colon of drug-treated or untreated mice, but it was present in most of the lesions. There was strong cytoplasmic expression in the mesenchymal cells, such as fibroblasts/ myofibroblasts and macrophages, in the areas of acute inflammation associated with erosions or ulceration of the mucosa ( Figure 6 ). There was also strong cytoplasmic expression of enterocytes in the colonic epithelium at the edges of these areas of ulceration, but very weak expression in the cancer cells. There was no expression of IRGA6 in the lymphocytes or neutrophils in the inflamed tissue. Immunity-related GTPase M3 (IRGM3) expression also mostly was absent in the normal colon apart from isolated plasma cells and endothelium of blood vessels. Inflammation induced IRGM3 expression in the colonic epithelium and also was seen in infiltrating plasma cells and macrophages ( Figure 6 ). 16, 18 or DSS (17%-22%). 38 The gene profiles in the inflamed tissue showed a much wider spectrum of the signaling pathways than previously recognized, including novel coding and noncoding genes. The data implicate activation of cancer-promoting genes and pathways in producing a premalignant tissue microenvironment, which does not involve b-catenin hyperactivation. We found that b-catenin protein expression was mainly localized in the epithelial cell membrane in the tumors. The lack of nuclear b-catenin hyperactivity was shared by both Mcc F/F and Mcc DIEC mice in our study and is similar to the mesenchymal CMS4 subtype in human beings, which may comprise up to 23% of colorectal cancers. 27 There are also other important similarities between sulindac-induced inflammation and Figure 2 . (See previous page). Validation of altered gene expression in inflammatory lesions. The mucosal lining was harvested from ileum, proximal P1 and P2, proximal P2 lesions, and distal colon of mice given either sulindac or the control diet (3-6 mice/group). In sulindac-fed mice, P2 refers to macroscopically normal-appearing tissue adjacent to the visible lesions. RNA expression was analyzed by triplicate qPCR and normalized to Gapdh. P values are shown only for the differences in the P2 region. A 2-tailed Mann-Whitney test was used to determine statistical significance. Error bars indicate the means with SD. mRNA, messenger RNA. CMS4 because many of the up-regulated gene expression pathways are the same (EMT, Inflammatory Response, Angiogenesis, Complement and TGF Beta Signaling). In addition, down-regulation of MYC target genes is characteristic for both Mcc DIEC mouse lesions and CMS4. Loss of MCC causes a slight decrease in epithelial cell proliferation in the normal colon, which could be related to a small impairment of the DNA damage response to a background level of DNA SSBs occurring in the healthy colon, but has no significant phenotypic effect in the adult mouse or during development. 39 In stressed inflammatory conditions a lack of MCC causes subtle but widespread down-regulation of pathways involved with DNA damage and replication, such as the G2M checkpoint and DNA repair ( Table 2 ). In the same conditions, MCC-expressing mice showed up-regulation of these pathways. This up-regulation is a normal response to DNA damage and replication stress caused by reactive oxygen and nitrogen species, which are generated by the inflammation. 40 Oxidative stress itself also is known to impair MMR protein function, which is thought to cause low-level MSI associated with chronic inflammation. 41 The gene expression changes observed here were 
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was expressed diffusely in the cytoplasm of normal colonic epithelium and was increased in mice exposed to sulindac. AHR expression was present in the inflammationassociated adenocarcinoma. Original magnification: (A, B, E, F, G inset) Â400, (C and D) Â200, and (G) Â100. Complete MMR deficiency also can cause a loss of the G2/M checkpoint after N-methyl-N 0 -nitro-N-nitrosoguanidine or tioguanine-induced DNA damage. 42 However, it is unclear whether our observations in Mcc DIEC mice are related to the same cellular process.
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Curiously, we also observed down-regulation of E2F target genes by GSEA of Mcc DIEC mice ( Table 2 ). The E2F transcription factor family plays a central role in the sequential expression and repression of genes required for cell-cycle progression, DNA repair, and replication. For example, MMR and many other DNA repair genes are transcribed by E2F. 43 Sustained E2F activity is a key cellular mechanism to allow cells to recover from DNA damage induced by replication stress and is mediated by activation of CHK1. [44] [45] [46] Because we showed that the absence of MCC prevented the phosphorylation of CHK1 in MEF cells exposed to the DNA damaging agent H 2 O 2 , it is possible that the Mcc DIEC mice failed to activate an E2F transcriptional cascade in response to excessive DNA damage and replication stress in the inflamed lesions. This suggests a role for MCC in the cell-cycle S-phase checkpoints that have evolved to respond to potential failures in DNA repair and replication. Defective E2F signaling contributes to genomic instability, a recognized hallmark of cancer. 47 Our study also described a previously unrecognized feature of mouse colitis, coordinated up-regulation of 28 members of the IFNg-induced GTPase superfamily that defends mammalian cells against a diverse group of invading pathogens, such as intracellular bacteria and protozoa. [48] [49] [50] [51] Here, this up-regulation was seen in the absence of external pathogen involvement in the inflamed colon and was restricted to immediate proximity of the damaged epithelial barrier that allows translocation of the gut microbiome. This feature has become evident in our study by using the latest generation microarrays that provide a much wider coverage of the genome. In the mouse there are 3 highly complex subfamilies, Irg, Gvin, and Gbp, each with different roles and functions. They have not been linked with carcinogenesis, although other GTPases, such as Ras, Rac, and Rho, are wellknown oncogenes and EMT promoters when mutated or up-regulated.
In the human colon, overexpression of a germline variant of the IRGM gene has been associated with susceptibility to Crohn's disease-associated chronic inflammation. 52, 53 In the mouse, IRG protein activation is more complex with 2 groups of factors, the regulatory GMS (IRGM1-3) and the effector GSK subfamily (multiple IRGA and IRGB proteins), which have complementary roles. Expression of some of the IRG proteins has been characterized in vitro in the context of intracellular bacterial or parasite infections and activation of the NLRP3 inflammasome. 50 Further studies are required to determine the functional consequences of the concordant expression of the Irg/noncoding RNA clusters in the inflamed tissue and whether there is any similarity to the defect of intracellular bacterial clearance in Crohn's disease that increases inflammation. 52, 53 It also is possible that the composition of the gut microbiome can affect the level of expression/activation of the IRG proteins and the severity of inflammation. It is well known that the severity and timing of experimental colitis can vary depending on the dosage and duration of drug exposure, mouse strain, housing conditions, and composition of the gut microbiome. 54 Therefore, these genes could be pursued further as potential markers of a pathogenic response to drug toxicity or severity of inflammation in the colon and its interplay with the gut microbiome.
It is likely that the strong inflammatory EMT and IFNg response observed in the 10-week lesions was caused by colon barrier destruction. However, sulindac exposure clearly was the trigger, possibly by causing the initial drug toxicity and erosion of the surface mucosa through increased AHR signaling. Sulindac is a ligand of AHR and can cause proinflammatory AHR, nuclear factor-kB (NFkB), and AP-1 Transcription Factor Subunit cJUN (cJUN) signaling in vitro that is reversed when AHR is knocked down. 18, 55 We . Log fold-change between the end points and controls were plotted for probe sets that were differentially expressed in both of the studies (blue, N ¼ 1602), this study only (green, N ¼ 702), or Fang et al 34 study only (pink, N ¼ 5637). IFNg-induced GTPases that were common for both studies are highlighted in black. A total of 10,957 probe sets that were not differentially expressed in either study were not plotted. (B) Validation of up-regulated Irga6 and Irgb6 expression in the inflammatory lesions (3-6 mice per group). RNA expression was analyzed by triplicate qPCR and normalized to Gapdh. A 2-tailed Mann-Whitney test was used to determine statistical significance. Error bars indicate the means with SD. (C) Expression of Irga6, Irgb6, and the chemokine Mip2 (positive control of inflammation) in the lesions from 3 independent mouse experiments (3 mice/experiment; 3 technical replicates/lesion also shown). Lesions and proximal control tissue were analyzed from the same mice. P values are shown only for the differences in the P2 region. Gene expression was analyzed by qPCR, and normalized to Gapdh expression. A 2-tailed Wilcoxon matched-pairs signed-rank test was used to determine statistical significance. Error bars indicate the means with SD. Exp, Experiment; prox, proximal colon adjacent to lesions.
showed previously that small lesions become visible and show up-regulation of NFkB target genes after 1 week of sulindac exposure. 16, 17 The tissue toxicity caused by nonsteroidal anti-inflammatory drugs (NSAID) is well documented in the human gastrointestinal tract. 56 A germline variant of CYP2C9 causes low activity of the enzyme and susceptibility to NSAID-associated gastrointestinal bleeding. 57 We observed a coordinated decrease in the expression of the drug response gene cluster Cyp2c67, Cyp2c68, Cyp2c40, and Cyp2c69, which are orthologues of human CYP2C9. Down-regulation of these genes also was found in DSS colitis 34 and thus may be more widely associated with drug-induced colon barrier destruction rather than being a sulindac-specific alteration.
This study has shown widespread similarities in the gene expression profiles of sulindac and DSS-induced colitis. Furthermore, similar to the azoxymethane/DSS model of colon cancer, male mice are more susceptible than female mice to cancer associated with sulindac-induced inflammation. 58 Although DSS colitis typically is diffuse and more NOTE. Gene nomenclature is from Lilue et al. 36 LincRNA, Long intergenic non-coding RNA; LncRNA, Long non-coding RNA. severe in the lower colon, this varies according to the molecular weight of DSS. A lower molecular weight (5 kilodaltons) of DSS is absorbed in the proximal colon/cecum and causes patchy lesions. 59 Therefore, the localization of sulindac-induced lesions in the mucosal folds of the proximal colon may be a combination of mechanical and biological factors.
Taken together, this study has provided evidence for the in vivo functional significance of MCC and has shown that the MCC knockout defect can drive carcinogenesis in the absence of b-catenin hyperactivity. It also has shown novel insights into the complexity of the inflammatory microenvironment that predisposes to malignancy in colorectal cancer.
Materials and Methods
Generation of New Mouse Lines
The Mcc-loxP mouse line (Mcc F/F ) was generated by Ozgene (Bentley, WA, Australia) ( Figure 1A 
In Vivo Proliferation Assay
Mcc D/D and wild-type siblings (Mcc-WT) were obtained from heterozygous crossings. Twenty-week-old mice were injected intraperitoneally with 100 mg/kg BrdU (SigmaAldrich, St. Louis, MO) and killed 2 hours after injection. The ileum and colon were harvested and fixed in 10% formalin for immunohistochemistry. Epitope retrieval was performed in a pressure cooker at 125ºC with DAKO (Glostrup, Denmark) buffer S2367, pH 9.0 for 2 minutes. The primary antibody for BrdU (1:50, DAKO) was incubated for 60 minutes. The number of BrdU-positive cells in each crypt were counted and divided by the total number of cells in each crypt to obtain the percentage of BrdU positivity. Twenty crypts were counted for each individual mouse and colon region.
Mouse Experimentation and Colon Tissue Analysis
Sulindac (320 ppm; Sigma-Aldrich) was mixed with standard chow by Specialty Feeds (Glen Forrest, Western Australia). Six-week-old mice were given feed containing sulindac or standard chow and killed after 20 weeks of sulindac exposure. The number and size of visible lesions in the proximal colon were determined under a dissecting microscope. The colon lesions underwent a biopsy examination (2-13/mouse) together with control specimens (20-22 mice per group, both males and females). 16, 18 After formalin fixation, processing, and sectioning using routine diagnostic laboratory methods, at least 2 H&E-stained sections per animal were analyzed by a specialist anatomical pathologist (J.E.D.) in a blinded fashion. For each biopsy specimen the features assessed included the following: type of inflammation (acute and/or chronic) and depth and severity of inflammation (absent, mild, moderate, or severe). Mucosal ulceration was regarded as severe acute inflammation and was defined as loss of the colonic mucosa associated with an acute inflammatory reaction extending at least through the muscularis mucosae. Mucosal erosion was regarded as moderate acute inflammation and was defined as superficial ulceration that involved only the surface epithelium and superficial underlying lamina propria. Epithelial dysplasia was graded as negative, indefinite for low-grade dysplasia, low-grade, or high-grade dysplasia according to the Riddell classification. Only biopsy specimens that showed neoplastic glands within a desmoplastic stroma extending beyond the muscularis mucosae were regarded as invasive cancer (invasive adenocarcinoma). 16, 18 For E-cadherin and b-catenin protein expression, heatinduced epitope retrieval of 3-mm tissue sections was performed for 25 seconds in a pressure cooker (total time, 30 min) using a citrate buffer at pH 6.0 (S1699; DAKO). The primary antibody was biotinylated with anti-mouse Fab fragment using the DAKO Animal Research Kit. The primary antibody for E-cadherin (1:500, 610181; BD Biosciences, Franklin Lakes, NJ) was incubated for 90 minutes, and for b-catenin (1:500, 610153; BD Biosciences) for 60 minutes. For AHR expression, heat retrieval of 3-mm tissue sections was performed for 48 minutes in CC1 buffer, with blocking for 8 minutes. Sections were stained with 1:50 dilution AHR antibody (ab84833; Abcam, Cambridge, UK). Ventana's OptiView 3,3 0 -diaminobenzidine tetra hydrochloride Immumohistochemistry Detection Kit was used to amplify and visualize the signals (Ventana, Roche, Basel, Switzerland). Omitting the primary antibody was the negative control and mouse prostate was the positive control. The slides were counterstained with hematoxylin.
For IRGA6 and IRGM3, heat-induced epitope retrieval of 3-mm tissue sections was performed for 10 minutes at 95ºC using Tris-EDTA buffer at pH 9.0. Detection of the primary antibodies, the anti-Irga6 serum (1:8000), 63 and anti-Irgm3 (1:100, sc-136317; Santa Cruz, Dallas, TX), was achieved with the ImmPRESS system (MP-7401; Vector, Burlingame, CA). The horseradish-peroxidase color reaction was performed with the peroxidase substrate kit HistoGreen (E109; Linaris, WertheimBettingen, Germany). The nuclei were counterstained with Nuclear Fast Red.
Mouse Transcriptome and Pathway Analysis
A subset of mice (5-8 per group, all males) was killed after 10 weeks of sulindac exposure and the colon mucosa was harvested by light scraping and snap-frozen. RNA was extracted (74104, RNeasy mini kit; Qiagen, Hilden, Germany). Gene expression profiling was conducted using Mouse Transcriptome Array 1.0 (Affymetrix) at the Ramaciotti Centre for Genomics (Sydney, Australia). Quality control was performed using the Affymetrix Expression Console. Normalization and probe-set summarization was performed using the robust multichip average method of the Affymetrix Power Tools apt-probe set-summarize software (version 1.16.1) (using the -a rma option) resulting in 72,688 transcript clusters. Mouse gene symbols were assigned to each transcript cluster using Affymetrix NetAfx annotations (version na34.1 mm10). Differential expression between experimental groups was assessed using limma via the limmaGP tool in GenePattern (Broad Institute, San Diego, CA). 64 Mouse gene symbols were mapped to human orthologs using version 78 of the Ensembl database (EMBL-EBI, Hinxton, UK). The transcript profiling data have been deposited at NCBI Gene Expression Omnibus (GSE84391-GEO) and is freely available at http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi? token¼kzwlcwasldsrfen&acc¼GSE84391.
Functionally associated gene sets were identified using GSEA on a ranked list of the limma moderated t statistics, from each pair-wise comparison, against the 50 Hallmark gene sets from v5.0 of the MSigDB (Broad Institute). 26 The most significantly down-regulated genes (Q < 0.05) in recognized DNA repair pathways were further identified with network analyses of the Mcc DIEC data (STRING, Cytoscape, KEGG) and pathway annotations in GeneCards.
Comparison of Sulindac-Induced Colon Inflammation and the DSS Colitis Model
Publicly available raw gene expression data from a previous DSS colitis experiment 34 were downloaded from GEO (accession GSE22307). Robust Multi-array Average (RMA) values were generated and differential expression between days 0 and 6 of DSS treatment was determined using limma 65 and compared with the data from this study (Mcc
F/F
). A probe set was considered differentially expressed in either study if Q < 0.05. The official gene symbol was used to map between array platforms, providing a total of 18,898 probe sets. Log fold-change between the end points and controls were plotted for probe sets that were differentially expressed in 1 or both of the studies. Correlations were calculated using the Pearson correlation coefficient (r).
qPCR Analysis cDNA was prepared using the Quantitect Reverse Transcription Kit (205311; Qiagen). Gene expression changes in
